Esya Labs Awarded $452,000 Grant from the Michael J. Fox Foundation (MJFF) to Develop Peripheral Biomarkers for Parkinson’s Disease
London, UK, November 4th, 2022 – Esya Labs, a startup dedicated to developing early-stage biomarkers for neurodegenerative diseases, has been awarded a grant of $452,000 from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). Esya Labs will be partnering with MSD (tradename of Merck & Co., Inc., Rahway, N.J.,
27/10/2023